Raffael Kurek

Raffael Kurek is a seasoned professional in the medical and pharmaceutical sectors, currently serving as Vice President and Global Program Lead at Bristol Myers Squibb since July 2023. Prior experience includes roles as Executive Medical Director and Group Leader in Early Global Development at AstraZeneca, as well as Senior Director in Clinical Development for Oncology R&D. Kurek has held significant positions at Eli Lilly and Company, leading Global Patient Safety Medical in Oncology, and at ImClone Systems as Associate Vice President in Global Clinical Sciences. Earlier career highlights include serving as Medical Leader in Oncology at Merck Group and Associate Head of Department at the University of Tübingen's Women's Hospital. Kurek's academic credentials include an Executive Management Certificate from INSEAD, a Specialist License in Obstetrics and Gynecology from the University of Tübingen, and a Doctorate in Medicine from Heidelberg University. Additionally, Kurek completed voluntary military service as a Paratrooper and Reserve Officer in the German Army.